Contribute Try STAT+ Today

Welcome to the corner office! We regularly turn to a new panel of biopharma executives for insights about leadership and management — and tips for thriving in a roller-coaster industry. To share your views in future columns, please fill out this short form. To suggest questions for our panelists,  email STAT Plus Editor Liz Cooney. This month, we asked:

What’s your top piece of advice for a student looking for a career in biopharma?

Parag Mehta, CEO, Aveta Biomics, Cambridge, Mass.: There has never been a better time to enter the pharmaceutical industry. Scientific advances of last couple of decades give high hopes to find cures for the diseases like never before. I would highly recommend to a student entering the pharmaceutical field to find an area of immense therapeutic interest to himself or herself, which serves as a motivation, a key ingredient for achieving success. Next, figure out the role he/she wants to play; be it in business area or in scientific or medical space.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.